Spotify
Google Podcasts
Apple Podcasts
Breaker
Overcast
Pocket Casts
Radio Public
Anchor
CytomX Therapeutics Stock Price (Quote) NASDAQ:CTMX
$4.36 ( -0.23% ) Wednesday, 26th Jan 2022
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $3.67 | $4.64 | Wednesday, 26th Jan 2022 CTMX stock ended at $4.36. This is 0.23% less than the trading day before Tuesday, 25th Jan 2022. During the day the stock fluctuated 7.18% from a day low at $4.32 to a day high of $4.63. |
| 90 days | $3.67 | $7.53 | |
| 52 weeks | $3.67 | $10.05 |
Historical CytomX Therapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2022-01-26 | $4.40 | $4.63 | $4.32 | $4.36 | 570 146 |
| 2022-01-25 | $4.24 | $4.43 | $4.17 | $4.37 | 658 614 |
| 2022-01-24 | $4.23 | $4.42 | $4.04 | $4.39 | 1 121 733 |
| 2022-01-21 | $4.12 | $4.38 | $4.10 | $4.29 | 947 278 |
| 2022-01-20 | $4.24 | $4.33 | $4.09 | $4.16 | 930 793 |
| 2022-01-19 | $3.87 | $4.16 | $3.83 | $4.08 | 1 055 077 |
| 2022-01-18 | $4.18 | $4.28 | $3.83 | $3.83 | 1 165 206 |
| 2022-01-14 | $3.70 | $3.95 | $3.67 | $3.95 | 720 976 |
| 2022-01-13 | $3.77 | $3.87 | $3.68 | $3.74 | 716 738 |
| 2022-01-12 | $4.02 | $4.02 | $3.75 | $3.76 | 668 341 |
| 2022-01-11 | $3.92 | $4.08 | $3.86 | $3.98 | 747 974 |
| 2022-01-10 | $3.86 | $3.93 | $3.73 | $3.93 | 696 788 |
| 2022-01-07 | $4.10 | $4.15 | $3.87 | $3.89 | 667 266 |
| 2022-01-06 | $3.97 | $4.16 | $3.90 | $4.12 | 895 700 |
| 2022-01-05 | $4.25 | $4.31 | $3.99 | $3.99 | 784 016 |
| 2022-01-04 | $4.59 | $4.64 | $4.17 | $4.19 | 1 063 532 |
| 2022-01-03 | $4.45 | $4.53 | $4.27 | $4.49 | 745 867 |
| 2021-12-31 | $4.24 | $4.45 | $4.22 | $4.33 | 642 763 |
| 2021-12-30 | $4.47 | $4.57 | $4.38 | $4.40 | 849 193 |
| 2021-12-29 | $4.31 | $4.53 | $4.27 | $4.47 | 956 956 |
| 2021-12-28 | $4.25 | $4.38 | $4.23 | $4.34 | 959 963 |
| 2021-12-27 | $4.16 | $4.33 | $4.08 | $4.23 | 1 380 287 |
| 2021-12-23 | $4.08 | $4.31 | $4.08 | $4.22 | 2 034 228 |
| 2021-12-22 | $3.81 | $4.14 | $3.74 | $4.05 | 3 973 353 |
| 2021-12-21 | $5.05 | $5.06 | $3.68 | $3.87 | 15 422 051 |
| 2021-12-20 | $6.33 | $6.51 | $5.89 | $6.45 | 1 189 599 |
| 2021-12-17 | $6.20 | $6.75 | $6.02 | $6.39 | 4 797 266 |
| 2021-12-16 | $6.70 | $6.75 | $6.30 | $6.32 | 854 405 |
| 2021-12-15 | $6.10 | $6.71 | $6.04 | $6.68 | 1 914 224 |
| 2021-12-14 | $6.35 | $6.35 | $5.84 | $6.05 | 1 123 338 |
| 2021-12-13 | $6.33 | $6.51 | $6.12 | $6.45 | 1 252 950 |
| 2021-12-10 | $6.20 | $6.43 | $6.20 | $6.29 | 991 440 |
| 2021-12-09 | $6.26 | $6.47 | $6.13 | $6.20 | 1 138 141 |
| 2021-12-08 | $5.79 | $6.27 | $5.69 | $6.26 | 856 799 |
| 2021-12-07 | $5.76 | $5.97 | $5.75 | $5.82 | 552 569 |
| 2021-12-06 | $6.60 | $6.60 | $5.44 | $5.73 | 1 125 382 |
| 2021-12-03 | $6.94 | $6.97 | $6.61 | $6.61 | 828 299 |
| 2021-12-02 | $6.67 | $6.91 | $6.62 | $6.90 | 876 142 |
| 2021-12-01 | $6.70 | $6.88 | $6.64 | $6.70 | 1 168 250 |
| 2021-11-30 | $6.52 | $6.89 | $6.42 | $6.61 | 2 274 572 |
| 2021-11-29 | $6.74 | $6.79 | $6.49 | $6.52 | 1 002 692 |
| 2021-11-26 | $6.95 | $6.96 | $6.74 | $6.75 | 829 123 |
| 2021-11-24 | $7.15 | $7.15 | $6.94 | $7.04 | 615 446 |
| 2021-11-23 | $7.26 | $7.29 | $7.02 | $7.21 | 1 255 933 |
| 2021-11-22 | $7.33 | $7.46 | $7.17 | $7.31 | 756 395 |
| 2021-11-19 | $7.13 | $7.35 | $7.10 | $7.34 | 783 448 |
| 2021-11-18 | $7.30 | $7.34 | $7.01 | $7.22 | 1 147 328 |
| 2021-11-17 | $7.35 | $7.53 | $7.26 | $7.37 | 896 423 |
| 2021-11-16 | $7.20 | $7.46 | $7.06 | $7.39 | 835 275 |
| 2021-11-15 | $7.16 | $7.41 | $7.10 | $7.26 | 953 729 |
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops novel class of antibody therapeutics based on its Probody technology platform that address clinically-validated cancer targets in immuno-oncology, such as PD-L1, as well as novel targets, comprising CD-166. In addition, it has strategic collaborations with Bristol-Myers Squibb Company, Pfizer Inc., ImmunoGen, Inc., and Th... Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!
Join 108 000+ Happy Subscribers
Don't miss out on the runners!
![StockInvest.us]()
Stock Podcast
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
